Investigators in this study assessed if either ranibizumab 0.5 mg monotherapy or ranibizumab 0.5 mg and laser therapy would be more efficacious than laser monotherapy.
Quiz Module 10.10
To validate your answers and keep track of your progress please sign in or register a new account
1. The RESTORE trial studied which agent?
2. The RESTORE trial concluded what regarding side effects of ranibizumab?
3. The results of the RESTORE Core Study concluded that: